Cardihab being used in a world leading long COVID study

Cardihab being used in a world leading long COVID study

4th August, 2021

Today the Baker Heart and Diabetes Institute announced a world leading investigation into the long-term heart damage caused by COVID-19. Hundreds of Melbourne COVID-19 survivors are being recruited for the study looking into the effects of what is dubbed “long COVID” — where those who have previously tested positive report complications months after they have recovered.

Read More
ImpaQT Group's support and investment in Cardihab

Cardihab are delighted to have ImpaQT Group investment

26th July, 2021

We are delighted to have the ImpaQT Group’s support and investment to help us to fulfil our mission of improving access to care for patients recovering from cardiac events and/or living with heart disease.

Read More

The Baker Institute and Cardihab collaborate to deliver new digital heart disease prevention and management approaches

26th July, 2021

Digital health will take transformative steps by supporting new clinical trials to address secondary prevention of Australia’s deadliest disease following an agreement between Australian digital health company Cardihab and medical research organisation, the Baker Heart and Diabetes Institute.

Read More
How digital solutions to cardiac rehabilitation are transforming patient outcomes webinar

Webinar recording: How digital solutions to cardiac rehabilitation are transforming patient outcomes

8th July, 2021

The webinar hosted by Australian Healthcare and Hospitals Association (AHHA) is now available to watch.

Read More
Cardihab’s recent raise campaign via the VentureCrowd crowd funding platform

Crowdfunding a heart-starter for stalled ventures

23rd June, 2021

Cardihab’s recent raise campaign via the VentureCrowd crowd funding platform caught the interest of journalist Jonathan Porter from the Australian Financial Review.

Read More
The Australian first partnership between Uniseed and VentureCrow

The Australian first partnership between Uniseed and VentureCrowd and the benefits for Cardihab

27th May, 2021

The Australian first partnership between Uniseed and VentureCrowd provides an important pathway for wholesale investors to support the growth and expansion of home grown digital health companies like Cardihab to achieve our potential.

Read More
How digital solutions to cardiac rehabilitation are transforming patient outcomes webinar

Webinar: How digital solutions to cardiac rehabilitation are transforming patient outcomes

7th May, 2021

The Australian Centre for Value-Based Health Care is pleased to bring you the next webinar in our webinar series on ‘How digital solutions to cardiac rehabilitation are transforming patient outcomes’.

Read More

Mike O’loughlin speaks with Helen Souris, CEO of Cardihab

1st April, 2021

Tassie Talks LAFM Host Michael O’Loughlin interviews Helen Souris CEO Cardihab.

Read More

Geoff Waring and Stoic Venture Capital commits further to healthcare following Cardihab success

30th March, 2021

We are incredibly thankful for the continued support from Geoff Waring and Stoic Venture Capital Fund ILP.

Read More

Cardiac patients in Tasmania can now seek digital rehabilitation

25th March, 2021

The adoption of Cardihab’s digital cardiac rehabilitation program across Tasmania is part of a growing global trend in leveraging validated digital health programs to manage chronic disease and prevent acute events.

Read More
MTP Connect

Adaptive regulation for digital health technologies – A pathway for industry seminar

17th March, 2021

This hosted by MTPConnect’s Andrew Bowskill and facilitated by Dr Lissette Pregelj (The University of Queensland).

Read More

Digital rehab for Tasmanian heart patients

17th March, 2021

Tasmanians living with heart disease will soon be able to rehabilitate from cardiac episodes virtually in an Australian-first deal with a state government.

Read More